Nano-X Imaging Shareholders Approve All Proposals at 2025 Annual Meeting

Nano-X Imaging ( (NNOX) ) has provided an announcement.

On December 23, 2025, Nano-X Imaging Ltd held its Annual General Meeting of Shareholders at its offices in Petach Tikva, Israel, where shareholders approved, by the required majority, all proposals presented in the company’s previously distributed notice and proxy materials. The approved matters have been incorporated by reference into Nano-X’s existing shelf and employee equity registration statements, a procedural step that aligns the company’s corporate and securities documentation with the latest shareholder authorizations and supports its ability to raise capital and administer equity-based compensation going forward.

The most recent analyst rating on (NNOX) stock is a Buy with a $7.00 price target. To see the full list of analyst forecasts on Nano-X Imaging stock, see the NNOX Stock Forecast page.

Spark’s Take on NNOX Stock

According to Spark, TipRanks’ AI Analyst, NNOX is a Neutral.

Nano-X Imaging’s overall stock score reflects its growth potential and strategic initiatives, balanced against significant financial challenges and valuation concerns. The company’s efforts in global expansion and technology development are promising, but profitability and cash flow issues remain critical risks.

To see Spark’s full report on NNOX stock, click here.

More about Nano-X Imaging

Nano-X Imaging Ltd is an Israel-based medical imaging technology company focused on developing and commercializing innovative X-ray imaging systems and related solutions for the global healthcare market. The company targets improving accessibility and reducing costs of advanced imaging, positioning itself within the broader medical device and diagnostic imaging industry.

Average Trading Volume: 1,723,954

Technical Sentiment Signal: Sell

Current Market Cap: $182.4M

For detailed information about NNOX stock, go to TipRanks’ Stock Analysis page.